Skip to content

The effects of flower essence therapies on people with alcohol withdrawal

Efficacy of Bach Flower Remedies in individuals with down Syndrome Alcohol Abstinence: a randomized controlled clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-7pzb4sw
Enrollment
Unknown
Registered
2023-08-07
Start date
2023-09-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol Abstinence

Interventions

At first, users who meet the criteria will be invited to participate and will be informed about all ethical and logistical precepts of the research, such as objectives and interventions, in addition t

Sponsors

Universidade Federal do Rio Grande do Norte
Lead Sponsor
Universidade Federal do Rio Grande do Norte
Collaborator

Eligibility

Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Female and male users, have a diagnosis of disorder related to alcohol abuse, be 18 years old or older, have been admitted to CAPS AD III, have an up-to-date Single Therapeutic Project (PTS), have been previously diagnosed with Down Syndrome Mild/moderate alcohol abstinence and being in overnight care (24-hour monitoring) for the first time.

Exclusion criteria

Exclusion criteria: Users who make use of multiple drugs, who have a previous allergy to any component of the Bach Flower Remedies, who for some reason have evaded the service, or any situation that interrupts continued follow-up (evasion or transfer to another device in the healthcare network). health).

Design outcomes

Primary

MeasureTime frame
It is expected that, through the clinical trial method, the study has shown a reduction in anxiety in individuals with Alcohol Withdrawal Syndrome through the evaluation parameters of the instruments used to verify the results. It is expected that the scores vary between 38 and 42 on the Likert scales to verify if what really happened in the pre- and post-interruptions exercises, with a variation of at least 5%.;It is expected that, through the randomized clinical trial, the study will show a reduction in cravings in individuals with Alcohol Withdrawal Syndrome through the evaluation parameters of the instruments used. In this sense, showing craving scores between 12 and 17 on the Likert scales to verify whether the outcome really happened in the pre- and post-intervention measurements.

Secondary

MeasureTime frame
Secondary outcomes are not expected.

Countries

Brazil

Contacts

Public ContactUniversidade do Rio Grande do Norte

Universidade Federal do Rio Grande do Norte

posenfermagemufrn@gmaiil.com+55(084)33422299

Outcome results

None listed

Source: REBEC (via WHO ICTRP)